# Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management

> **NCT02271893** · PHASE2 · TERMINATED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 19 (actual)

## Conditions studied

- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **DRUG:** Dextromethorphan

## Key facts

- **NCT ID:** NCT02271893
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11-25
- **Primary completion:** 2017-10-26
- **Final completion:** 2022-04-21
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271893, "Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02271893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*